Article Text

Download PDFPDF
IDDF2024-ABS-0263 PET117 promotes ferroptosis in colorectal cancer cells through regulation of mitochondrial metabolism
  1. Qiong Sun1,
  2. Mengdi Zhang2,
  3. Jing Han3,
  4. Xiaolong Guo3,
  5. Junjun She3
  1. 1Yulin Hospital, First Affiliated Hospital of Xi’an Jiao Tong University, Yulin, China
  2. 2Department of Dermatology, Second Affiliated Hospital of Xi’an Jiao Tong University, Xi’an, China
  3. 3Department of Talent Highland, First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an, China

Abstract

Background The precise involvement of mitochondria in ferroptosis in CRC cells remains unclear. We previously demonstrated that PET117 is a significant mitochondrial protein, while its deletion induces mitochondrial dysfunction. Our proteomic analysis found that PET117 was associated with ferroptosis. Hence, we hypothesize that PET117 regulates ferroptosis in CRC cells by modulating mitochondrial metabolism.

Methods The study aims to elucidate the role of PET117 in CRC ferroptosis using cell, mouse and colorectal tumor models and investigate PET117’s regulation of CRC mitochondrial function through approaches such as seahorse analysis and metabolomics. Additionally, we will identify PET117-interacting proteins and elucidate their regulatory mechanisms by integrating multi-omics detection of tumor tissue and gene-edited cells.

Results The Cancer Genome Atlas (TCGA) analysis unveiled an up-regulation of PET117 mRNA in CRC tissues compared to normal colorectal tissues. According to proteomic analysis of control and PET117-KO cells, we found that loss of PET117 altered mitochondrial proteome and was associated with ferroptosis. Importantly, compared with the control group, loss of PET117 inhibited erastin or RSL3-induced ferroptosis, while overexpression of PET117 in PET117-KO cells increased sensitivity to erastin or RSL3-induced ferroptosis. In addition, using DCFH-DA fluorescent probe to label ROS in RSL3-treated control or PET117-KO cells, the flow cytometry results showed that RSL3 significantly increased ROS in RSL3-induced ferroptosis in control cells, interestingly, the ROS did not significantly change in PET117-KO cells. Meanwhile, the loss of PET117 didn’t affect cell apoptosis or autophagy. Next, RNA-seq analysis showed that the absence of PET117 altered the expression of ferroptosis-related genes. Finally, we conducted a phosphorylated proteomic analysis of control and PET117-KO cells, we found that the loss of PET117 reconstructed the cellular phosphorylation network signal. We integrated Uniprot database, PhosphoSitePlus database, and String database, and analyzed the detected phosphorylated proteins with known ferroptosis pathway proteins, and draw phosphorylation networks. The results showed that PET117 regulates phosphorylation in the STAT3-TP53 signaling pathway.

Conclusions Our study reveals that PET117 is significantly upregulated in CRC and exerts a pro-ferroptotic effect. PET117 may serve as a potential target for CRC treatment.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.